Small exosome packages act as communication vehicles between cells, much like todays Twitter messages and by intercepting this communication we can now listen in on the cells language to detect cancer earlier as well as see how cancer is changing over time.
In this video, ExosomeDx lead researcher, Lisa Meyer walks us through a newly developed workflow for detecting MISEV recommended extracellular vesicle (EV) protein markers using automated western blotting.
Recent findings from a real-world clinical study underscore how EPI supports clinical decision making and motivate sometimes unwilling patients to proceed to or defer prostate biopsy. In addition, this tool was proven to detect more high-grade prostate cancers over standard of care parameters alone.
Dr. David M. Albala, Chief of Urology at Crouse Hospital in Syracuse, New York, explores the novel ExoDx Prostate™ and the growing demand for diagnostic tools that provide prognostic information to identify the right patient to undergo biopsy at the right time.
Learn more about exosomes in our webinar with Dr. Skog, one of the first scientists to discover exosomes. He will provide an overview of exosomes, dynamics and physiology, exosomes as mediators of infectious disease, therapeutics and diagnostics.